(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-N-carboxamide derivatives
The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
04.07.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain. |
---|---|
Bibliography: | Application Number: AU20090327575 |